News

Dr Bobotas has been president and managing partner of DeMelleBioPharma, since 2008. Dr Bobotas was employed at Reliant Pharmaceuticals, a wholly owned subsidiary of GlaxoSmithKline, for eight years

Mr Monast will report to Gregory Weishar, the company’s president and CEO. Mr Monast will be responsible for PharMerica’s pharmacy, clinical and billing operations, customer services and account

Last week, an EPA administrator told GlobalChem attendees that EPA may soon decide to regulate nanomaterials. According to the official, this rulemaking would be in reaction to a

Allos Therapeutics, a biopharmaceutical company, has reported new data demonstrating the anticancer activity of its investigational drug, pralatrexate, in colon, ovarian, lung, prostate, and head and neck cancer

VR315 is being developed as a generic product delivered with Vectura’s GyroHaler dry powder inhaler delivery device. Vectura licensed the European rights for VR315 to Sandoz, the generics

The certificate of compliance has a five-year term and was issued by the State Food and Drug Administration following a site inspection. Good Manufacturing Practice (GMP) is a

The Seeplex meningitis ACE detection tests for 12 meningitis-causing pathogens: five bacteria (S pneumoniae, N meningitidis, H influenzae type b, L monocytogenes, and S agalactiae); and seven viruses

China Biologic Products, a Chinese biopharmaceutical company, has completed the third installment payment towards the acquisition of a 90% equity interest in Chongqing Dalin Biologic Technologies, or Dalin,

Osiris Therapeutics, a stem cell therapeutic company, has completed patient enrollment in its pivotal, Phase III trial evaluating Prochymal as a first-line treatment for acute graft versus host